Ranbaxy Laboratories after market hours, reported consolidated net
loss of Rs 454.16 crore in Q3 September 2013, compared with net
profit of Rs 754.17 crore in Q3 September 2012. Total income
increased 1.92% to Rs 2827.73 crore in Q3 September 2013 over
Q3 September 2012. Ranbaxy Laboratories said that the loss is
due to depreciation of the rupee against the dollar.